Cite
Tan B, Khattak A, Felip E, et al. Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort. Target Oncol. 2021;16(4):435-446doi: 10.1007/s11523-021-00809-2.
Tan, B., Khattak, A., Felip, E., Kelly, K., Rich, P., Wang, D., Helwig, C., Dussault, I., Ojalvo, L. S., & Isambert, N. (2021). Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort. Targeted oncology, 16(4), 435-446. https://doi.org/10.1007/s11523-021-00809-2
Tan, Benjamin, et al. "Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort." Targeted oncology vol. 16,4 (2021): 435-446. doi: https://doi.org/10.1007/s11523-021-00809-2
Tan B, Khattak A, Felip E, Kelly K, Rich P, Wang D, Helwig C, Dussault I, Ojalvo LS, Isambert N. Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort. Target Oncol. 2021 Jul;16(4):435-446. doi: 10.1007/s11523-021-00809-2. Epub 2021 May 19. PMID: 34009501; PMCID: PMC8266790.
Copy
Download .nbib